色播亚洲精品网站亚洲第一,免费特级黄毛片,北条麻妃久久99精品,最近最新的日本中文字幕,国产精品猎奇系列在线观看,亚洲视频一区二区三区,一级做a毛片在线看

資訊|論壇|病例

搜索

首頁 醫(yī)學(xué)論壇 專業(yè)文章 醫(yī)學(xué)進(jìn)展 簽約作者 病例中心 快問診所 愛醫(yī)培訓(xùn) 醫(yī)學(xué)考試 在線題庫 醫(yī)學(xué)會(huì)議

您所在的位置:首頁 > 心血管內(nèi)科診療指南 > 2011RCOG靜脈血栓栓塞和激素替代療法

2011RCOG靜脈血栓栓塞和激素替代療法

2014-05-15 11:19 閱讀:1729 來源:愛愛醫(yī) 責(zé)任編輯:張子玲
[導(dǎo)讀] Exogenous estrogens used in the combined oral contraceptive pill have long been recognised as causativefactors in the pathogenesis of venous thromboembolism (VTE).

    《2011RCOG靜脈血栓栓塞和激素替代療法》內(nèi)容簡(jiǎn)介:

    Exogenous estrogens used in the combined oral contraceptive pill have long been recognised as causativefactors in the pathogenesis of venous thromboembolism (VTE)。1,2Hormone replacement therapy (HRT),either sequential or continuous combined, also exposes women to exogenous estrogen and a number ofcase–control studies and prospective randomised trials have shown an increase in the relative risk of VTE inwomen on estrogen-containing HRT.3In particular, the Women's Health Initiative (WHI) study in the USAassessed the major health benefits of oral HRT (0.625 mg conjugated equine estrogen and 2.5 mgmedroxyprogesterone acetate [MPA] daily) in a randomised placebo-controlled clinical trial with more than8000 women in each arm and confirmed an increase in the risk of pulmonary embolism (hazard ratio 2.13,95% CI 1.39–3.25)。4On the available evidence, however, a substantial risk of VTE may relate only to oral andnot to transdermal preparations.3Thus, the risk of VTE and the type of preparation must be considered inwomen starting or continuing HRT.

    《2011RCOG靜脈血栓栓塞和激素替代療法》內(nèi)容預(yù)覽:

    This guideline was developed using the standard methodology for developing RCOG Green-top Guidelines.5–7Original articles for the evidence base for this guideline were obtained following a computer search for'hormone replacement' as a keyword and also in combination with 'venous thrombosis' or 'deep venousthrombosis' (DVT) or 'pulmonary embolism' or 'thrombophilia' applied to Medline (1966 to week 1, 2010),Embase (1980 to week 1, 2010), Evidence-based Medicine Reviews, the Cochrane Database of SystematicReviews and the Database of Abstracts of Reviews of Effectiveness to the last quarter of 2009. This wascomplemented by hand searching for individual references identified from these original articles.The levelsof evidence and the grade of recommendations used in this guideline are detailed in RCOG ClinicalGovernance Advice No. 1a–c.5–7Where possible, recommendations are based on, and explicitly linked to, theevidence that supports them.Areas lacking evidence are highlighted and annotated as good practice points.

    點(diǎn)擊下載***:《2011RCOG靜脈血栓栓塞和激素替代療法》


分享到:
  版權(quán)聲明:

  本站所注明來源為"愛愛醫(yī)"的文章,版權(quán)歸作者與本站共同所有,非經(jīng)授權(quán)不得轉(zhuǎn)載。

  本站所有轉(zhuǎn)載文章系出于傳遞更多信息之目的,且明確注明來源和作者,不希望被轉(zhuǎn)載的媒體或個(gè)人可與我們

  聯(lián)系z(mì)lzs@120.net,我們將立即進(jìn)行刪除處理

意見反饋 關(guān)于我們 隱私保護(hù) 版權(quán)聲明 友情鏈接 聯(lián)系我們

Copyright 2002-2024 Iiyi.Com All Rights Reserved